Assure Holdings Corp Secures Nasdaq Listing Extension, Demonstrating Commitment to Compliance and Growth
DENVER, May 16, 2024 - Assure Holdings Corp. (NASDAQ: IONM), a leading provider of intraoperative neuromonitoring (IONM) and remote neurology services, has announced that it has received a written notice from the Nasdaq Listing Qualifications Panel (the Hearings Panel) granting the company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market. This decision by the Panel affirms Assure’s commitment to maintaining its NASDAQ listing and further solidifies its position as a key player in the healthcare technology sector.
The Hearings Panel has granted Assure an extension until July 22, 2024, providing the company with ample time to demonstrate compliance with all applicable initial listing requirements for the Nasdaq Capital Market. This extension is particularly linked to Assure’s completion of its previously announced transaction with Danam Health Inc. a strategic move that will further enhance the company’s growth prospects and strengthen its position in the market.
Assure Holdings Corp specializes in providing vital intraoperative neuromonitoring services, revolutionizing the way neurologists and surgeons collaborate during complex procedures. Through advanced technologies and remote neurology services, Assure enables real-time monitoring and analysis, ensuring the utmost precision and avoiding potential risks throughout the surgical process.
By securing this listing extension, Assure ensures that its shareholders and investors can continue to benefit from the opportunities presented by the Nasdaq Capital Market. This decision underscores the confidence of the Hearings Panel in Assure’s management and its ability to meet the necessary listing criteria. It provides a strong signal to the market that Assure’s long-term growth prospects remain intact, setting the stage for increased investor confidence and potential partnerships.
Assure Holdings Corp has positioned itself as a pioneer in the field of healthcare technology, leveraging cutting-edge advancements in intraoperative neuromonitoring. Through its innovative solutions and services, the company is poised to address the growing demand for enhanced patient care and operational efficiency in the surgical industry.
With the deadline set for July 22, 2024, Assure Holdings Corp is diligently working to meet all financial and operational requirements to regain compliance with the Nasdaq Capital Market. The company’s dedicated team, coupled with its unique and state-of-the-art offerings, positions it for success in this endeavor.
The granting of this extension serves as a testimony to Assure’s steadfast dedication to upholding the highest standards of corporate governance and financial diligence. Assure’s focus on compliance and commitment to navigate regulatory challenges exemplifies its mission to deliver value to its shareholders and drive positive impacts in the healthcare industry.
Conclusively, Assure Holdings Corp’s recent extension granted by the Nasdaq Listing Qualifications Panel underscores the company’s unwavering commitment to Nasdaq compliance, emphasizing its continued growth trajectory. As the company continues to pave the way in intraoperative neuromonitoring and remote neurology services, the future looks promising for Assure Holdings Corp and its stakeholders, solidifying its position as a leader in the healthcare technology landscape.
Comments